Cost of CRT - D Worldwide

Cardiac Resynchronisation Therapy with a Defibrillator (CRT-D) treats certain forms of heart failure, particularly in patients with reduced ejection fraction and abnormal electrical conduction (e.g., left bundle branch block). It combines two treatments: defibrillation, which guards against sudden cardiac death brought on by potentially fatal arrhythmias, and cardiac resynchronisation, which helps the heart's chambers beat in unison. When there is a high risk of deadly arrhythmias or when medication alone is not enough to control symptoms, CRT-D is advised.

If you experience signs of heart failure, such as exhaustion, dyspnea, edema in your legs, or fainting spells, you should consult a cardiologist. CRT-D may be taken into consideration if you have been diagnosed with heart failure with reduced ejection fraction (HFrEF), particularly if your ECG shows a large QRS complex. It’s also appropriate for patients with a history of cardiac arrest or prolonged ventricular arrhythmias. The ideal time for device therapy is determined in part by early consultation.

An ECG, echocardiography, chest X-ray, and occasionally a cardiac MRI or Holter monitor will be performed to evaluate heart function and rhythm before CRT-D installation. Medication evaluations and blood tests are performed, particularly if you are taking blood thinners. Before the surgery, you will need to fast for a few hours. Your physician will outline the surgery procedures and give you preoperative instructions.

• Implantation: Implantation involves inserting three leads into the heart and placing the device beneath the skin close to the left collarbone.
• Programming: The device is configured to detect and prevent harmful arrhythmias and synchronise heartbeats.
• Monitoring: After closing the incision, the patient is watched to ensure proper function.

The CRT-D implantation usually takes two to four hours. The majority of patients spend one to two days in the hospital. Physical activity, particularly arm motions on the implantation side, should be minimised during the typical one to two-week recovery period.

• Infection or bleeding at the implant site
• Lead displacement
• Pneumothorax (collapsed lung)
• Inappropriate shocks
• Device malfunction (rare)

CRT-D dramatically lowers the risk of sudden cardiac death, improves heart function, and lessens the symptoms of heart failure. It also reduces hospitalisations and allows patients to return to regular activities with less weariness.

Recovery includes wound care, arm movement restrictions, and careful device performance monitoring. Checking battery life and modifying device settings require follow-up visits. Regular imaging, ECG monitoring, and cardiac rehabilitation are all part of long-term care.